[8/27]
WHO ±Û·Î¹ú COVID-19 ¿ªÇÐ µ¿Çâ
(COVID-19 Global Epidemiological Update )
Coronavirus Disease (COVID-19) µ¿Çâ Highlights
ÁÖ¿ä ±¹°¡º° COVID-19 È®ÁøÀÚ, Ä¡¸í·ü ¹× ¿ÏÄ¡À²
COVID-19 ±¹¿Ü¹ß»ýÇöȲÀº Áö¿ªº°·Î ¾Æ½Ã¾ÆÁö¿ª 29°³±¹, Áßµ¿Áö¿ª 18°³±¹, ¾Æ¸Þ¸®Ä«Áö¿ª 35°³±¹, À¯·´Áö¿ª 49°³±¹, ¿À¼¼¾Æ´Ï¾ÆÁö¿ª 4°³±¹, ¾ÆÇÁ¸®Ä«Áö¿ª 49°³±¹, ±×¿Ü ±âŸÁö¿ª Æ÷ÇÔÇÏ¿© Àü¼¼°èÀûÀ¸·Î È®ÁøÀÚ´Â 24,036,022¸í, »ç¸ÁÀÚ 822,606¸íÀ¸·Î »ç¸Á·ü 3.42%·Î ³ªÅ¸³²(2020³â8¿ù27ÀÏ 09½Ã±âÁØ).
Ç¥1) ¼¼°èº¸°Ç±â±¸(WHO) Áö¿ªº° COVID-10 È®ÁøÀÚ, Ä¡¸í·ü (WHO Situation Report-209)
±¸ºÐ
|
¾ÆÇÁ¸®Ä«
|
¾Æ¸Þ¸®Ä«
|
µ¿ºÎÁöÁßÇØ
|
À¯·´
|
µ¿³²¾Æ½Ã¾Æ
|
¼ÅÂÆò¾ç
|
È®ÁøÀÚ(¸í)
|
945,165
|
11,420,860
|
1,723,673
|
3,754,649
|
3,040,168
|
409,589
|
»ç¸ÁÀÚ(¸í)
|
18,476
|
414,326
|
45,704
|
214,092
|
59,875
|
9,293
|
Ä¡¸í·ü(CFR)
|
1.94%
|
3.63%
|
2.65%
|
5.70%
|
1.97%
|
2.27%
|
Ç¥ 2 ) COVID-19 ÁÖ¿ä ¹ß»ý±¹°¡ µ¿Çâ(´©Àû¹ß»ý 20¸¸ ÀÌ»ó ±¹°¡) [´ÜÀ§ : ¸í]
±¹°¡/ÀÏ
|
08.23
|
08.24
|
08.25
|
08.26
|
08.27
|
´©Àû
»ç¸ÁÀÚ
|
¹Ì±¹
|
5,664,736
|
5,699,804
|
5,735,771
|
5,775,416
|
5,817,538
|
(179,596)
|
ºê¶óÁú
|
3,582,362
|
3,605,783
|
3,622,861
|
3,669,995
|
3,717,156
|
(117,66)
|
Àεµ
|
2,975,701
|
3,044,940
|
3,106,348
|
3,167,323
|
3,234,474
|
(59,449)
|
·¯½Ã¾Æ
|
951,897
|
956,749
|
961,493
|
966,189
|
970,865
|
(16,683)
|
³²¾ÆÇÁ¸®Ä«°øȱ¹
|
603,338
|
607,045
|
609,773
|
611,450
|
613,017
|
(13,308)
|
Æä·ç
|
576,067
|
585,236
|
594,326
|
600,438
|
607,382
|
(28,001)
|
¸ß½ÃÄÚ
|
556,216
|
560,164
|
563,705
|
568,621
|
573,888
|
(62,076)
|
ÄÝ·Òºñ¾Æ
|
513,719
|
522,138
|
533,103
|
541,147
|
551,696
|
(17,612)
|
½ºÆäÀÎ
|
386,054
|
386,054
|
405,436
|
412,553
|
419,849
|
(28,971)
|
Ä¥·¹
|
395,708
|
397,665
|
399,568
|
400,985
|
402,365
|
(10,990)
|
À̶õ
|
356,792
|
358,905
|
361,150
|
363,363
|
365,606
|
(21,020)
|
¾Æ¸£ÇîƼ³ª
|
320,884
|
329,043
|
336,802
|
342,154
|
350,867
|
(7,402)
|
¿µ±¹
|
324,601
|
325,642
|
326,614
|
327,798
|
328,846
|
(41,465)
|
»ç¿ìµð¾Æ¶óºñ¾Æ
|
306,370
|
307,479
|
308,654
|
309,768
|
310,836
|
(3,755)
|
¹æ±Û¶óµ¥½Ã
|
290,360
|
292,625
|
294,598
|
297,083
|
299,628
|
(4,028)
|
ÆÄÅ°½ºÅº
|
292,174
|
292,765
|
293,261
|
293,711
|
294,193
|
(6,267)
|
ÀÌÅ»¸®¾Æ
|
258,136
|
259,345
|
260,298
|
261,174
|
262,540
|
(35,458)
|
ÅÍÅ°
|
257,032
|
258,249
|
259,692
|
261,194
|
262,507
|
(6,183)
|
ÇÁ¶û½º
|
238,002
|
242,899
|
244,854
|
248,158
|
253,587
|
(30,544)
|
µ¶ÀÏ
|
233,854
|
234,483
|
236,121
|
237,583
|
239,010
|
(9,285)
|
À̶óÅ©
|
201,050
|
204,341
|
204,341
|
207,985
|
215,784
|
(6,668)
|
Ç¥ 3)ÁÖ¿ä ±¹°¡ COVID-19 È®ÁøÀÚ ¹× »ç¸ÁÀÚ ÇöȲ(08.27 09½Ã ±âÁØ)
±¹°¡
|
°¨¿°ÀÚ
|
»ç¸ÁÀÚ
|
»ç¸Á·ü
|
Àοø
|
¹ß»ý·ü (*)
|
Àοø
|
¹ß»ý·ü (*)
|
¹Ì±¹
|
5,817,538
|
1767.71
|
179,596
|
54.6
|
3.09
|
ºê¶óÁú
|
3,717,156
|
1750.07
|
117,665
|
55.4
|
3.17
|
Àεµ
|
3,234,474
|
236.32
|
59,449
|
4.3
|
1.84
|
·¯½Ã¾Æ
|
970,865
|
674.68
|
16,683
|
11.6
|
1.72
|
³²¾ÆÇÁ¸®Ä«°øȱ¹
|
613,017
|
1055.11
|
13,308
|
22.9
|
2.17
|
Æä·ç
|
607,382
|
1846.15
|
28,001
|
85.1
|
4.61
|
¸ß½ÃÄÚ
|
573,888
|
433.78
|
62,076
|
46.9
|
10.82
|
ÄÝ·Òºñ¾Æ
|
551,696
|
1107.82
|
17,612
|
35.4
|
3.19
|
½ºÆäÀÎ
|
419,849
|
904.85
|
28,971
|
62.4
|
6.9
|
Ä¥·¹
|
402,365
|
2148.24
|
10,990
|
58.7
|
2.73
|
À̶õ
|
365,606
|
441.55
|
21,020
|
25.4
|
5.75
|
¾Æ¸£ÇîƼ³ª
|
350,867
|
777.98
|
7,402
|
16.4
|
2.11
|
¿µ±¹
|
328,846
|
490.81
|
41,465
|
61.9
|
12.61
|
»ç¿ìµð¾Æ¶óºñ¾Æ
|
310,836
|
911.54
|
3,755
|
11.0
|
1.21
|
¹æ±Û¶óµ¥½Ã
|
299,628
|
185.64
|
4,028
|
2.5
|
1.34
|
ÆÄÅ°½ºÅº
|
294,193
|
143.79
|
6,267
|
3.1
|
2.13
|
ÀÌÅ»¸®¾Æ
|
262,540
|
443.48
|
35,458
|
59.9
|
13.51
|
ÅÍÅ°
|
262,507
|
316.27
|
6,183
|
7.4
|
2.36
|
Çʸ®ÇÉ
|
197,164
|
182.39
|
3,038
|
2.8
|
1.54
|
Àεµ³×½Ã¾Æ
|
157,859
|
58.57
|
6,858
|
2.5
|
4.34
|
Ä«ÀÚÈ彺ź
|
127,664
|
686.37
|
1,781
|
9.6
|
1.4
|
Áß±¹
|
85,004
|
5.99
|
4,634
|
0.3
|
5.45
|
ÀϺ»
|
64,668
|
50.96
|
1,226
|
1.0
|
1.9
|
½Ì°¡Æ÷¸£
|
56,495
|
957.54
|
27
|
0.5
|
0.05
|
Å°¸£Å°½º½ºÅº
|
43,358
|
699.32
|
1,058
|
17.1
|
2.44
|
¿ìÁŰ½ºÅº
|
39,790
|
121.31
|
289
|
0.9
|
0.73
|
È£ÁÖ
|
25,053
|
99.81
|
525
|
2.1
|
2.1
|
¸»·¹À̽þÆ
|
9,285
|
28.57
|
125
|
0.4
|
1.35
|
ű¹
|
3,402
|
4.91
|
58
|
0.1
|
1.7
|
º£Æ®³²
|
1,034
|
1.1
|
29
|
0.0
|
2.8
|
Çѱ¹
|
18,706
|
36.1
|
313
|
0.6
|
1.67
|
(*) Àα¸ 10¸¸ ¸í´ç (±¹°¡º° ÃÑ Àα¸¼ö : Çѱ¹ - 2020³â 1¿ù ÇàÁ¤¾ÈÀüºÎ Áֹεî·ÏÀα¸ÇöȲ ±âÁØ , Çѱ¹ ¿Ü - United Nations Population Fund(UNFPA, À¯¿£Àα¸±â±Ý) )
Ç¥ 4) ÁÖ¿ä ±¹°¡ °ËÁø°Ç¼ö ¹× È®Áø·ü ºñ±³(08.27. 00½Ã ±âÁØ)
±¹°¡
|
°Ë»ç°Ç¼ö
|
È®ÁøÀÚ
|
°Ç¼ö´ëºñ È®Áø·ü
|
Áß±¹
|
N/A
|
83,891¸í
|
N/A
|
Çѱ¹
|
1,526,974°Ç
|
14,175¸í
|
0.9 %
|
ÀÌÅ»¸®¾Æ
|
N/A
|
246,118¸í
|
N/A
|
À̶õ
|
N/A
|
291,172¸í
|
N/A
|
ÀϺ»
|
720,501°Ç
|
29,989¸í
|
4.2 %
|
¹Ì±¹
|
N/A
|
4,234,140¸í
|
N/A
|
¿µ±¹
|
14,794,369°Ç
|
299,426¸í
|
2.0 %
|
* N/AÇ¥½Ã´Â ¹ÌÁý°è¸¦ ÀǹÌÇÔ Ãâó : Á߾ӹ濪´ëÃ¥º»ºÎ Á¤·Êºê¸®ÇÎÀÚ·á
±×¸² 1) COVID-19 È®Áø ±¹°¡ ¹× Áö¿ªº° È®Áø »ç·Ê(2020³â8¿ù27ÀÏÀÚ WHO º¸°í)
Source: WHO Coronavirus disease (COVID-19) Situation Report -209 [¹Ù·Î°¡±â]
±×¸² 2) COVID-19 È®Áø ¿ªÇа(³¯Â¥º°, Áö¿ªº° 2019³â 12¿ù~2020³â 8¿ù16ÀÏÀÚ)
Source: WHO Coronavirus disease 2019 (COVID-19) Situation Report 209 [»ó¼¼º¸±â]
[¿¬±¸µ¿Çâ] Coronavirus 2019 (COVID-19)] Highlights
COVID-19 ȯÀÚ °øº¹Ç÷´ç(FBG)Àº »ç¸Á·ü ¿¹ÃøÁöÇ¥
Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study
ÃֽŠÀ¯·´ ´ç´¢º´ÇÐȸÁö Diabetologia, EASD (European Association for Study of Diabetes) ¹ßÇ¥¿¡ ÀÇÇϸé, COVID-19 °¨¿°À¸·Î ÀÎÇØ ÀÔ¿øÇÑ È¯ÀÚÀÇ ÀÔ¿ø ½Ã¿¡ ÃøÁ¤ÇÑ °øº¹ Ç÷´ç(FBG)Àº COVID-19 ¿¹ÈÄ¿¡ ´ëÇÑ Áõ»ó ¾ÇȻӸ¸ ¾Æ´Ï¶ó, 28ÀÏ »ç¸ÁÀ²( 28-day mortality)À» ¿¹ÃøÇÒ ¼ö ÀÖ´Â ÁöÇ¥°¡ µÈ´Ù´Â ¿¬±¸ °á°ú¸¦ º¸°íÇß´Ù. [»ó¼¼º¸±â]
COVID-19 ¸é¿ª¹ÝÀÀ -- Ç×ü 2°³¿ù°£ ¾ÈÁ¤ÀûÀ¸·Î Áö¼Ó
(COVID-19 immune response may remain stable for two months after diagnosis)
¿µ±¹ ·±´ø ¼¼ÀÎÆ® Á¶Áö ´ëÇаú º´¿ø(St George's, University of London & St George's University Hospitals NHS Foundation Trust)°ú ¸®¹öÇ® ÀÇÇÐ ¿¬±¸ÆÀ(Liverpool School of Tropical Medicine, Mologic Ltd. and Institut Pasteur de Dakar, Sénégal)ÀÌ Äڷγª-19 È®ÁøÀÚ 177¸íÀ» ´ë»óÀ¸·Î ÁøÇàÇÑ Ç×ü°Ë»ç °á°ú, COVID-19 °¨¿° Áø´Ü ÈÄ °ÅÀÇ 2 °³¿ùÀÌ Áö³ª¼ °¨¿°µÈ »ó´ç ¼öÀÇ È¯ÀÚÇ÷¾×¿¡¼ Ç×ü°¡ ¾ÈÁ¤ÀûÀ¸·Î À¯ÁöµÈ´Ù´Â º¸°í°¡ ¹ßÇ¥µÇ¾ú´Ù. [»ó¼¼º¸±â]
[NEJM Ãֽŵ¿Çâ] COVID-19 ÈæÀΰú ¹éÀÎȯÀÚÀÇ ÀÔ¿øÀ²°ú »ç¸Á·ü ºñ±³
Hospitalization and Mortality among Black Patients and White Patients with Covid-19
·çÀÌÁö¾Ö³ªÁÖÀÇ ´ë±Ô¸ð ÄÚȣƮ¿¬±¸¸¦ ÅëÇÏ¿© Covid-19·Î ÀÔ¿ø ÇÑ È¯ÀÚÀÇ 76.9 %¿Í »ç¸Á ȯÀÚÀÇ 70.6 %´Â ÈæÀÎÀ¸·Î ³ªÅ¸³µÀ¸³ª, ÀÔ¿ø ½Ã »çȸÀα¸ Åë°èÇÐÀû ¹× ÀÓ»óƯ¼ºÀÇ Â÷À̸¦ Á¶Á¤ÇÑ ÈÄ, ÈæÀÎ ÀÎÁ¾Àº ¹éÀÎ ÀÎÁ¾º¸´Ù º´¿ø ³» »ç¸Á·üÀÌ ³ôÁö ¾ÊÀ½À¸·Î ³ªÅ¸³µ´Ù. [»ó¼¼º¸±â]
NIH- Remdesivir (·½µ¥½Ãºñ¸£) COVID-19 Ä¡·áÁ¦·Î ½ÂÀÎ
¹Ì±¹ ±¹¸³º¸°Ç¿¬±¸¿ø(NIH)ÀÌ ¼öÇàÇÑ Ç×¹ÙÀÌ·¯½º ·½µ¥½Ãºñ¾î(remdesivir) ÀÓ»ó½ÃÇ迬±¸ °á°ú°¡ NEJM (New England Journal of Medicine.)À» ÅëÇØ ¹ßÇ¥µÇ¾ú´Ù. (https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=featured_home)
ÀÌ °á°ú¸¦ ±Ù°Å·Î 5¿ù 1ÀÏ¿¡ ¹Ì±¹ FDA(½Ä¾àó)´Â ·½µ¥½Ãºñ¾î¸¦ ¡¸ÁßÁõ¡¹È¯ÀÚ(»ê¼ÒÆ÷ȵµ <94%, »ê¼Ò Ä¡·á ÇÊ¿ä)¿¡°Ô ±ä±Þ»ç¿ëÇã°¡¸¦ ½ÂÀÎÇÏ¿´À¸¸ç, ÀÌÁ¦ ·½µ¥½Ãºñ¾î°¡ COVID-19ÀÇ Ç¥ÁØ Ä¡·áÁ¦·Î »ç¿ëÇã°¡µÇ¾ú´Ù. [»ó¼¼º¸±â]
[±¹³»Ç÷ÀåÄ¡·á¼º°ø] COVID-19: ¿ÏÄ¡ÀÚ Ç÷ÀåÄ¡·á(Convalescent Plasma)
±¹³» ¼¼ºê¶õ½ºº´¿ø ¿¬±¸ÆÀÀº ¿ÏÄ¡ÀÚ Ç÷Àå(Convalescent Plasma) Ä¡·á¹æ¹ýÀ¸·Î ÀÓ»ó¿¡¼ Coronavirus disease 2019 (COVID-19)ÀÇ ¿ÏÄ¡ »ç·Ê¸¦ º¸°íÇß´Ù. ÀÌ°ÍÀº Çѱ¹¿¡¼ COVID-19¿¡ ´ëÇÑ ¿ÏÄ¡ÀÚ Ç÷Àå Ä¡·á¿¡ ´ëÇÑ Ã¹ ¹ø° ÀÓ»ó ¿ÏÄ¡»ç·ÊÀÌ´Ù. [»ó¼¼º¸±â]
COVID-19 Ä¡·áÁ¦°³¹ß ±Û·Î¹ú Àӻ󿬱¸ ÇÁ·ÎÁ§Æ®ÇöȲ
½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(Äڷγª19) Ä¡·áÁ¦ °³¹ßÀ» À§ÇØ Àü¼¼°è°¡ ³ë·ÂÇÏ°í ÀÖ´Â °¡¿îµ¥, ÇöÀç Äڷγª 19 Ä¡·áÁ¦ °³¹ß°ú °ü·Ã ±¹Á¦ÀûÀ¸·Î Àӻ󿬱¸°¡ 335,815°ÇÀÌ ÁøÇà Áß¿¡ ÀÖ´Ù(2020³â 4¿ù 13ÀÏÀÚ µî·ÏÇöȲ). ¹Ì±¹ ±¹¸³º¸°Ç¿ø NIH ClinicalTrials.gov¿¡ µî·ÏµÇ¾î ÁøÇàÇÏ°í ÀÖ´Â COVID-19 °ü·Ã Àӻ󿬱¸´Â 300¿©°Ç ÀÌ»óÀÌ ÁøÇà Áß¿¡ ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)±¹Á¦Àӻ󿬱¸µî·Ï Ç÷§Æû(World Health Organization's International Clinical Trials Registry Platform, WHO ICTRP)¿¡¼´Â 590°ÇÀÇ ÇÁ·ÎÁ§Æ®°¡ ÇöÀç Àӻ󿬱¸ Áß¿¡ ÀÖ´Ù. [»ó¼¼º¸±â]
NEJM COVID-19 º¸°í [½ÉÇ÷°üÁúȯ ¾à¹°Ä¡·á, »ç¸Á·ü ¿äÀÎ ¿¬±¸(Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19): Angiotensin-converting–enzyme (ACE) inhibitors & angiotensin-receptor blockers (ARBs)]
º» ¿¬±¸´Â The New England Journal of Medicine 2020³â 5¿ù 1ÀÏÀÚ ¹ßÇ¥µÈ COVID-19 ½ÉÇ÷°üÁúȯÀÇ ¾à¹°Ä¡·á- Angiotensin-converting–enzyme (ACE) inhibitors¿Í Angiotensin-receptor blockers (ARBs) »ç¿ë¿¡ ´ëÇÑ ÀáÀçÀû À§Çؼº Æò°¡¿Í »ç¸Á·ü °ü·Ã¿äÀÎ ¿¬±¸ÀÌ´Ù.
º´¿ø ³» »ç¸ÁÀ² Áõ°¡¿Í °ü·ÃÀÖ´Â µ¶¸³¿äÀεéÀº ¾Æ·¡¿Í °°´Ù.
1. 65¼¼ ÀÌ»ó ¿¬·É( (mortality of 10.0%, vs. 4.9% among those ≤65 years of age; odds ratio, 1.93; 95% confidence interval [CI], 1.60 to 2.41) (65 ¼¼ ¹Ì¸¸ÀÇ »ç¸Á·üÀº 10.0 %, »ç¸Á·üÀº 4.9 %)
2. °ü»óµ¿¸Æ Áúȯ(10.2%, vs. 5.2% among those without disease; OR, 2.70; 95% CI, 2.08 to 3.51)
3. ½ÉºÎÀü(15.3%, vs. 5.6% among those without heart failure; OR 2.48; 95% CI, 1.62 to 3.79)
4. ½ÉÀåºÎÁ¤¸Æ(11.5%, vs. 5.6% among those without arrhythmia; OR, 1.95; 95% CI, 1.33 to 2.86)
5. ¸¸¼ºÆó¼â¼ºÆóÁúȯ(14.2%, vs. 5.6% among those without disease; OR, 2.96; 95% CI, 2.00 to 4.40)
6. ÇöÀç Èí¿¬(9.4%, vs. 5.6% among former smokers or nonsmokers; OR, 1.79; 95% CI, 1.29 to 2.47)
¾à¹°Ä¡·á¿Í »ç¸Á·ü°úÀÇ °ü·ÃÀ» ºÐ¼®ÇÑ °á°ú, ACE inhibitors (2.1% vs. 6.1%; OR, 0.33; 95% CI, 0.20 to 0.54) »ç¿ëÀ̳ª, ARB(6.8% vs. 5.7%; OR, 1.23; 95% CI, 0.87 to 1.74) ¾à¹°Ä¡·á´Â º´¿ø³»¿¡¼ »ç¸ÁÀ§ÇèÀ» Áõ°¡½ÃÅ°´Â °Í°ú °ü·ÃÀÌ ¾ø´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù. [¿ø¹®º¸±â]
COVID-19: ÁßÁõ ¼ºÀÎȯÀÚ ICU ÆÐÇ÷Áõ °¡À̵å¶óÀÎ
ÁßÁõ±Þ¼ºÈ£Èí±âÁõÈıºÀ» ¾ß±âÇÏ´Â SARS-CoV-2´Â Àü¼¼°èÀûÀ¸·Î ±Þ¼ÓÇÏ°Ô È®»êµÇ°í ÀÖÀ¸¸ç ¼ö¸¹Àº »ç¶÷µéÀÇ »ý¸íÀ» À§ÇùÇÏ°í ÀÖ´Ù. À̵éÀ» µ¹º¸´Â º¸°ÇÀÇ·áÀεé°ú ÀÓ»óÀǻ縦 À§ÇÑ ±ä±ÞÇÑ °¡À̵å¶óÀÎ °³¹ßÀÌ ÇÊ¿äÇÏ´Ù. COVID-19·Î ÀÎÇÑ ÆÐÇ÷Áõ °ü¸® ÁöħÀ» À§ÇØ ±¸¼ºµÈ ÆгÎÀº 54°³ÀÇ Áø¼ú¹®À» ¸¸µé¾ú°í ÀÌÁß¿¡¼ 4°¡Áö º£½ºÆ® ½Ç¹«°¡À̵å¶óÀΰú 9°¡Áö °·ÂÇÑ ±Ç°í»çÇ×°ú, 35°¡Áö ¾ÆÁ÷Àº Áõ°Å°¡ ºÎÁ·ÇÑ Á¦¾ÈµéÀº ¹ßÇ¥Çß´Ù. [´õº¸±â]
Ç¥ 5) Coronavirus disease (COVID-19) ±¹³» ¹× ±¹¿Ü COVID -19 ÃֽŠÁ¤º¸ ¹Ù·Î°¡±â
Ç¥ 6) Coronavirus disease (COVID-19) ÃֽŠÇмúÁ¤º¸ »çÀÌÆ® ¹Ù·Î°¡±â
Ãâó
Çѱ¹ : Á߾ӹ濪´ëÃ¥º»ºÎ Á¤·Êºê¸®ÇÎ º¸µµÀÚ·á
WHO, Coronavirus (COVID-19) Situation report-209
Áß±¹ : ±¹°¡À§»ý°Ç°À§¿øȸ ȨÆäÀÌÁö
ÀÌÅ»¸®¾Æ : º¸°ÇºÎ ȨÆäÀÌÁö
ÀϺ» : ÈÄ»ý³ëµ¿¼º º¸µµÀÚ·á
¿µ±¹ : Á¤ºÎ»çÀÌÆ®
À̶õ · ¹Ì±¹ : Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE
±âÁØ
-°Ç¼ö´ëºñ È®ÁøÀ²(È®ÁøÀÚ¼ö/°Ë»ç°Ç¼ö × 100)´Â ¿Â¶óÀο¡ °ø°³µÈ °¢±¹ÀÇ °Ë»ç°Ç¼ö ¹× È®ÁøÀÚ ¼ö¸¦ Åä´ë·Î ÀÚü °è»ê
-Áß±¹ ( 08¿ù 25ÀÏ 24½Ã ±âÁØ) , Çѱ¹ ( 08¿ù 26ÀÏ 00½Ã ±âÁØ) , ÀÌÅ»¸®¾Æ ( 08¿ù 26ÀÏ 00½Ã ±âÁØ) , À̶õ ( 08¿ù 26ÀÏ 08½Ã ±âÁØ) , ÀϺ» ( 08¿ù 26ÀÏ 00½Ã ±âÁØ) , ¹Ì±¹ ( 08¿ù 26ÀÏ 08½Ã ±âÁØ) , ¿µ±¹ ( 08¿ù 26ÀÏ 00½Ã ±âÁØ)
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ Á¦°ø
2020-08-27 ¿ÀÈÄ 3:51:11, Á¶È¸¼ö : 2417
|